101 related articles for article (PubMed ID: 9248815)
1. The importance of standardisation and validation of symptom scores and quality of life: the urologist's point of view.
O'Leary M
Eur Urol; 1997; 32 Suppl 2():48-9. PubMed ID: 9248815
[TBL] [Abstract][Full Text] [Related]
2. Cultural and linguistic validation of questionnaires for use in international studies: the nine-item BPH-specific quality-of-life scale.
Boyle P
Eur Urol; 1997; 32 Suppl 2():50-2. PubMed ID: 9248816
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
[TBL] [Abstract][Full Text] [Related]
4. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association.
Barry MJ; Fowler FJ; O'Leary MP; Bruskewitz RC; Holtgrewe HL; Mebust WK
Med Care; 1995 Apr; 33(4 Suppl):AS145-55. PubMed ID: 7536866
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of symptoms in patients with benign prostatic hyperplasia].
Cornu JN; Rouprêt M
Prog Urol; 2007 Sep; 17(5 Suppl 1):1023-5. PubMed ID: 17969783
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.
Eckhardt MD; van Venrooij GE; van Melick HH; Boon TA
J Urol; 2001 Aug; 166(2):563-8. PubMed ID: 11458069
[TBL] [Abstract][Full Text] [Related]
7. [Quality of life assessment of the male with benign prostate hypertrophy].
Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
[TBL] [Abstract][Full Text] [Related]
8. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
Chalise PR; Agrawal CS
Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
[TBL] [Abstract][Full Text] [Related]
9. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia: treat or wait?
Davidson JH; Chutka DS
J Fam Pract; 2008 Jul; 57(7):454-63. PubMed ID: 18625168
[TBL] [Abstract][Full Text] [Related]
12. Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score.
Ushijima S; Ukimura O; Okihara K; Mizutani Y; Kawauchi A; Miki T
J Urol; 2006 Aug; 176(2):665-71. PubMed ID: 16813918
[TBL] [Abstract][Full Text] [Related]
13. Changes in disease specific and generic quality of life related to changes in lower urinary tract symptoms: the Krimpen study.
Kok ET; Bohnen AM; Groeneveld FP; Busschbach JJ; Blanker MH; Bosch JL
J Urol; 2005 Sep; 174(3):1055-8. PubMed ID: 16094057
[TBL] [Abstract][Full Text] [Related]
14. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.
Donovan JL; Kay HE; Peters TJ; Abrams P; Coast J; Matos-Ferreira A; Rentzhog L; Bosch JL; Nordling J; Gajewski JB; Barbalias G; Schick E; Silva MM; Nissenkorn I; de la Rosette JJ
Br J Urol; 1997 Nov; 80(5):712-21. PubMed ID: 9393291
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
O'Leary MP; Wei JT; Roehrborn CG; Miner M;
BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
[TBL] [Abstract][Full Text] [Related]
16. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
[TBL] [Abstract][Full Text] [Related]
17. Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction.
Marklund-Bau H; Edéll-Gustafsson U; Spångberg A
Scand J Urol Nephrol; 2007; 41(1):32-41. PubMed ID: 17366100
[TBL] [Abstract][Full Text] [Related]
18. Effects of transurethral resection of prostate on the quality of life of patients with benign prostatic hyperplasia.
O'Sullivan M; Murphy C; Deasy C; Iohom G; Kiely EA; Shorten G
J Am Coll Surg; 2004 Mar; 198(3):394-403. PubMed ID: 14992742
[TBL] [Abstract][Full Text] [Related]
19. Transurethral water-induced thermotherapy for the treatment of benign prostatic hyperplasia: a prospective multicenter clinical trial.
Muschter R; Schorsch I; Danielli L; Russel C; Timoney A; Yachia D; Jolkowsky E; Matalon G; Roder T; Nordling J
J Urol; 2000 Nov; 164(5):1565-9. PubMed ID: 11025705
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of lower urinary tract symptoms on generic and disease-specific quality of life in men and women.
Araki I; Tsuchida T; Nomura T; Fukasawa M; Takihana Y; Koyama N; Takeda M
Urol Int; 2008; 81(1):60-5. PubMed ID: 18645273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
